Fluxome solvency hinges on omega-3 funding02 October 2012Resveratrol manufacturer Fluxome faces a “funding crisis” and could be bankrupt in 2-3 months unless it can secure investment to pay for a switch to omega-3 production. Jarne Elleholm, Fluxome’s chair said that bankruptcy of both its Danish and US operations would be the likely result if 3-4 potential investors did not support its transition into the supply of omega-3 extracted from yeast. “We are speaking with 3-4 interested parties including industry players and capital funds and expect to have a clear picture on how to move forward in 8-12 weeks,” Elleholm told NutraIngredients. Fluxome, which is owned by venture capital firms in Denmark, Belgium and France, has applied to the Danish courts for a “formal reconstruction” of its business – a process that will take 8-12 weeks to resolve. The firm’s Danish office remains closed but Ellholm said that its US operations are unaffected by the court action. | |
 Exhibitions Fi Europe | Hi/Ni China | Fi India | Fi Asia | Fi South America | Health ingredients Europe, Ni & NuW | Fi Istanbul Languages      
| |
